WO2009027823A3 - Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. - Google Patents
Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. Download PDFInfo
- Publication number
- WO2009027823A3 WO2009027823A3 PCT/IB2008/002346 IB2008002346W WO2009027823A3 WO 2009027823 A3 WO2009027823 A3 WO 2009027823A3 IB 2008002346 W IB2008002346 W IB 2008002346W WO 2009027823 A3 WO2009027823 A3 WO 2009027823A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- processes
- tissular
- trophism
- dermal
- wound healing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22002—Papain (3.4.22.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses pharmaceutical compositions for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes for internal and external use, containing gentamicin sulphate, metronidazole, papain, metronidazole Balsam of Peru, and an excipient or vehicle pharmaceutically acceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP070103846A AR062835A1 (en) | 2007-08-29 | 2007-08-29 | A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION |
ARP20070103846 | 2007-08-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2009027823A2 WO2009027823A2 (en) | 2009-03-05 |
WO2009027823A3 true WO2009027823A3 (en) | 2009-04-23 |
WO2009027823A9 WO2009027823A9 (en) | 2009-09-03 |
Family
ID=40225122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/002346 WO2009027823A2 (en) | 2007-08-29 | 2008-08-29 | Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR062835A1 (en) |
WO (1) | WO2009027823A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012095702A1 (en) * | 2011-01-13 | 2012-07-19 | Medestea Internazionale S.P.A. | A composition for the regeneration of atrophic tissues |
CN102241712B (en) * | 2011-05-23 | 2014-04-02 | 南阳普康药业有限公司 | Decolorizing method for gentamicin sulfate production |
CN104435345A (en) * | 2014-11-11 | 2015-03-25 | 四川金堂海纳生物医药技术研究所 | Orally taken medicine for treating pulpitis and preparation method thereof |
BE1024364B9 (en) * | 2016-06-29 | 2018-03-07 | Holding Tolpoort Bvba | COMPOSITION FOR TREATMENT OF PERNIOSIS |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2028130A (en) * | 1978-05-30 | 1980-03-05 | Acf Chemiefarma Nv | Pharmaceutical wound-treating compositions containing allantoin |
WO2000038617A2 (en) * | 1998-12-24 | 2000-07-06 | Four Star Partners | Compositions and methods of using the same |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
US20070154402A1 (en) * | 2005-10-24 | 2007-07-05 | Collegium Pharmaceutical, Inc. | Topical Pharmaceutical Foam Composition |
WO2007084127A1 (en) * | 2006-01-20 | 2007-07-26 | Verdon Peters | Use of gluten for wound treatment as active healing ingredient |
WO2007099398A2 (en) * | 2005-09-27 | 2007-09-07 | Naturalite Benelux B.V. | Methods and compositions for treatment of skin |
-
2007
- 2007-08-29 AR ARP070103846A patent/AR062835A1/en not_active Application Discontinuation
-
2008
- 2008-08-29 WO PCT/IB2008/002346 patent/WO2009027823A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2028130A (en) * | 1978-05-30 | 1980-03-05 | Acf Chemiefarma Nv | Pharmaceutical wound-treating compositions containing allantoin |
WO2000038617A2 (en) * | 1998-12-24 | 2000-07-06 | Four Star Partners | Compositions and methods of using the same |
US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
WO2007099398A2 (en) * | 2005-09-27 | 2007-09-07 | Naturalite Benelux B.V. | Methods and compositions for treatment of skin |
US20070154402A1 (en) * | 2005-10-24 | 2007-07-05 | Collegium Pharmaceutical, Inc. | Topical Pharmaceutical Foam Composition |
WO2007084127A1 (en) * | 2006-01-20 | 2007-07-26 | Verdon Peters | Use of gluten for wound treatment as active healing ingredient |
Also Published As
Publication number | Publication date |
---|---|
AR062835A1 (en) | 2008-12-10 |
WO2009027823A9 (en) | 2009-09-03 |
WO2009027823A2 (en) | 2009-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009085990A3 (en) | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof | |
IL195142A (en) | Substituted arylimidazolone and triazolone, process for their preparation and pharmaceutical compositions comprising the same for the treatment or prophylaxis of diseases | |
WO2006119329A3 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
WO2009056550A3 (en) | Bupropion hydrobromide and therapeutic applications | |
WO2010003313A8 (en) | Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof | |
WO2008035373A3 (en) | Highly pure polysialic acid and process for preperation thereof | |
WO2007117971A3 (en) | Ocular allergy treatments | |
WO2007051468A3 (en) | Preparation of an antibiotic crystalline fusidic acid | |
WO2010009200A3 (en) | Methods for treating oral cavity infections with chlorine dioxide | |
WO2009019294A3 (en) | Bupropion hydrobromide and therapeutic applications | |
WO2008008495A3 (en) | Stereocomplex-forming composition and implantable medical device comprising same | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2011077239A3 (en) | Slow release pharmaceutical compositions of iloperidone | |
WO2007109799A3 (en) | Polymorphs of eszopiclone malate | |
WO2008051564A3 (en) | Crystalline forms of palonosetron hydrochloride | |
WO2007123740A3 (en) | Pharmaceutical compositions for promoting wound healing | |
EP4223759A4 (en) | Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof | |
HK1103961A1 (en) | Medicament for the treatment of fungal infections, particularly aspergillosis | |
WO2009027823A3 (en) | Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. | |
WO2009142428A3 (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
WO2009120389A8 (en) | Oral and injectable formulations of tetracycline compounds | |
EP2392335A3 (en) | Use of 24-norUDCA | |
EP1584335A3 (en) | Active substance combination comprising a carbinol composition and an opioid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08807036 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08807036 Country of ref document: EP Kind code of ref document: A2 |